Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,958 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
IL-8 and cathepsin B as melanoma serum biomarkers.
Zhang H, Fu T, McGettigan S, Kumar S, Liu S, Speicher D, Schuchter L, Xu X. Zhang H, et al. Among authors: fu t. Int J Mol Sci. 2011;12(3):1505-18. doi: 10.3390/ijms12031505. Epub 2011 Feb 25. Int J Mol Sci. 2011. PMID: 21673904 Free PMC article.
Challenges in the clinical utility of the serum test for HER2 ECD.
Lam L, McAndrew N, Yee M, Fu T, Tchou JC, Zhang H. Lam L, et al. Among authors: fu t. Biochim Biophys Acta. 2012 Aug;1826(1):199-208. doi: 10.1016/j.bbcan.2012.03.012. Epub 2012 Apr 3. Biochim Biophys Acta. 2012. PMID: 22521738 Free PMC article. Review.
Inhibitory DNA Aptamer Tools against SOCS3-gp130 Interactions.
Zhang X, Hou Y, Chen W, Fu T, Wei Y, Tan W. Zhang X, et al. Among authors: fu t. ACS Appl Mater Interfaces. 2024 Nov 21. doi: 10.1021/acsami.4c09252. Online ahead of print. ACS Appl Mater Interfaces. 2024. PMID: 39571081
Olverembatinib After Failure of Tyrosine Kinase Inhibitors, Including Ponatinib or Asciminib: A Phase 1b Randomized Clinical Trial.
Jabbour E, Oehler VG, Koller PB, Jamy O, Lomaia E, Hunter AM, Uspenskaya O, Samarina S, Mukherjee S, Cortes JE, Baer MR, Zherebtsova V, Shuvaev V, Turkina A, Davydkin I, Guo H, Chen Z, Fu T, Jiang L, Wang C, Wang H, Yang D, Zhai Y, Kantarjian H. Jabbour E, et al. Among authors: fu t. JAMA Oncol. 2024 Nov 21:e245157. doi: 10.1001/jamaoncol.2024.5157. Online ahead of print. JAMA Oncol. 2024. PMID: 39570620
2,958 results